Eagle Pharmaceuticals
EGRX
#10556
Rank
โ‚ฌ2.83 M
Marketcap
0,22ย โ‚ฌ
Share price
0.00%
Change (1 day)
-83.97%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚ฌ2.83 Million

As of March 2026 Eagle Pharmaceuticals has a market cap of โ‚ฌ2.83 Million. This makes Eagle Pharmaceuticals the world's 10556th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ2.83 M-42.96%
2025โ‚ฌ4.96 M-27.52%
2024โ‚ฌ6.84 M-88.85%
2023โ‚ฌ61.44 M-82.68%
2022โ‚ฌ0.35 B-38.92%
2021โ‚ฌ0.58 B17.69%
2020โ‚ฌ0.49 B-32.51%
2019โ‚ฌ0.73 B49.18%
2018โ‚ฌ0.49 B-26.24%
2017โ‚ฌ0.66 B-43.09%
2016โ‚ฌ1.16 B-7.94%
2015โ‚ฌ1.26 B608.84%
2014โ‚ฌ0.17 B

End of Day market cap according to different sources

On Mar 24th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚ฌ2.83 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ488.05 B 17,236,448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ247.28 B 8,733,244.40%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚ฌ695.71 B 24,570,423.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ161.68 B 5,709,999.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ100.60 B 3,552,938.56%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ92.10 B 3,252,695.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ29.21 B 1,031,629.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel